MiR-148b inhibited the proliferation and invasion of pancreatic cancer cells by targeting AMPKa1, and acted as a tumor suppressor in the development and progression of pancreatic cancer (Bloomston et al., 2007). Here, PRKAA1 is linked to pancreatic neoplasm.